维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

5篇 您的检索式：作者名="Michael Frink"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Tip apex distance, hip screw placement, and neck shaft angle as potential risk factors for cut-out failure of hip screws after surgical treatment of intertrochanteric fractures显示文摘	Hagen Andruszkow Michael Frink Cornelia Fr?mke Amir Matityahu Christian Zeckey Philipp Mommsen Stefanie Suntardjo Christian Krettek Frank Hildebrand	2012	International Orthopaedics2012，，11：	2
	2	Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma显示文摘	Konstantinos Raymondos Michael U. Martin Tanja Schmudlach Stefan Baus Christian Weilbach Tobias Welte Christian Krettek Michael Frink Frank Hildebrand	2011	Injury2011，，2：	1
	3	Surgical strategies in polytraumatized patients with femoral shaft fractures-comparing a German and an Australian level I trauma centre 显示文摘	Hagen Andruszkow Adam S Dowrick Michael Frink	2013	Injury2013，44，8：	1
	4	Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma显示文摘	Konstantinos Raymondos Michael U. Martin Tanja Schmudlach Stefan Baus Christian Weilbach Tobias Welte Christian Krettek Michael Frink Frank Hildebrand	2011	Injury2011，，2：	1
	5	Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review显示文摘BACKGROUND Increasing numbers of total joint arthroplasties and consecutive revision surgery are associated with the risk of periprosthetic joint infections (PPJI). Treatment of PPJI is complex and associated with immense socio-economic burden. One treatment aspect is parenteral antiinfective therapy, which usually requires an inpatient setting [Inpatient parenteral antibiotic therapy (IPAT)]. An alternative is outpatient parenteral treatment [Outpatient parenteral antibiotic therapy (OPAT)]. To conduct a health economic cost-benefit analysis of OPAT, a detailed cost analysis of IPAT and OPAT is required. So far, there is a lack of knowledge on the health economic effects of IPAT and OPAT for PPJI. AIM To review an economic comparison of IPAT and OPAT. METHODS A systematic literature review was performed through Medline following the PRISMA guidelines. RESULTS Of 619 identified studies, 174 included information of interest and 21 studies were included for quantitative analysis of OPAT and IPAT costs. Except for one study, all showed relevant cost savings for OPAT compared to IPAT. Costs for IPAT were between 1.10 to 17.34 times higher than those for OPAT. CONCLUSION There are only few reports on OPAT for PPJI. Detailed analyses to support economic or clinical guidelines are therefore limited. There is good clinical evidence supporting economic benefits of OPAT, but more high quality studies are needed for PPJI.	Christoph Kolja Boese Philipp Lechler Michael Frink Michael Hackl Peer Eysel Christian Ries	2019	World Journal of Clinical Cases2019，7，14：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费